Ophthalmology · El Paso, TX
NPI
1003075094
Since 2008
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2900 Pershing Dr, Suite A
El Paso, TX, 79903
Phone (915) 538-5171
Groups this clinician bills Medicare through
Medicare paid, 2024
$60K
600 services
Medicare patients, 2024
267
Average age 73
Drug cost, 2024
$1.6M
6,446 prescriptions
Company payments, 2025
$1,334
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mario A Di Pascuale was code 92012 (ophthalmological e&m), 135 times for 101 patients. In total Mario A Di Pascuale billed 600 services in 25 codes, and Medicare paid $60K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-04-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92012 Ophthalmological E&M | Office | 135 | 101 | $65.43 | $8,833 |
| 92014 Ophthalmological E&M | Office | 107 | 101 | $87.96 | $9,412 |
| 92004 Ophthalmological E&M | Office | 74 | 74 | $106.05 | $7,848 |
| 92250 Angiography | Office | 73 | 72 | $27.59 | $2,014 |
| 92136 Ultrasound - Nonspecific | Office | 66 | 49 | $33.07 | $2,183 |
| 66984 Cataract Surgery | Facility | 46 | 28 | $428.77 | $20K |
| 66821 Cataract Surgery | Office | 20 | 14 | $239.59 | $4,792 |
| 92133 Computerized Ophthalmic Imaging | Office | 16 | 16 | $21.27 | $340 |
| 92083 Vision, Hearing, and Speech Services | Office | 13 | 12 | $45.23 | $588 |
By year: 2022 $84K for 872 services; 2023 $87K for 868 services; 2024 $60K for 600 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mario A Di Pascuale prescribed most often to Medicare patients was Moxifloxacin (Moxifloxacin Hcl), with 1,128 prescriptions and refills. In total Mario A Di Pascuale wrote 6,446 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Moxifloxacin Moxifloxacin Hcl | 1,128 | 1,131 | 663 | $33K |
| Ketorolac Tromethamine Generic | 908 | 1,249 | 608 | $19K |
| Latanoprost Generic | 816 | 1,136 | 264 | $5,824 |
| Prednisolone Acetate Generic | 560 | 605 | 329 | $17K |
| Lotemax Sm Loteprednol Etabonate | 529 | 535 | 327 | $130K |
| Restasis Cyclosporine | 231 | 273 | 92 | $164K |
| Fluorometholone Generic | 191 | 274 | 123 | $16K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 183 | 339 | 58 | $2,625 |
| Xiidra Lifitegrast | 172 | 273 | 68 | $192K |
| Vyzulta Latanoprostene Bunod | 164 | 210 | 44 | $50K |
| Erythromycin Erythromycin Base | 145 | 145 | 64 | $1,855 |
| Prolensa Bromfenac Sodium | 141 | 141 | 99 | $50K |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 127 | 183 | 43 | $9,130 |
| Lumigan Bimatoprost | 101 | 127 | 21 | $30K |
| Timolol Maleate Generic | 101 | 173 | 36 | $2,208 |
Brand drugs: 2,974 claims; generic drugs: 3,472 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mario A Di Pascuale $1,334 ($1,334 in general payments such as food, travel and fees) from 11 companies. The largest payer was Heidelberg Engineering, Inc. with $270.
| Company | Payments | Amount |
|---|---|---|
| Heidelberg Engineering, Inc. | 1 | $270 |
| Carl Zeiss Meditec USA, Inc. | 4 | $213 |
| RxSight Inc RXST | 2 | $193 |
| Bausch & Lomb Americas Inc. BLCO | 8 | $188 |
| Novo Nordisk Inc NVO | 1 | $125 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 1 | $115 |
| Alcon Vision LLC ALC | 3 | $82.11 |
| Dompe US, Inc. | 2 | $66.08 |
| Sight Sciences, Inc. SGHT | 2 | $34.46 |
| Glaukos Corporation GKOS | 1 | $28.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.